Blood test shows promise for early detection of acute heart transplant rejectionDNA-based “liquid biopsy” could help save lives and reduce health disparities. They estimate that the test could eliminate up to 80% of invasive heart tissue biopsies currently used to detect rejection. Current tests used to detect heart transplant rejection rely on frequent and painful biopsies of heart tissue. The researchers monitored the patients for signs of acute rejection for nearly 18 months using both traditional endomyocardial (heart tissue) biopsy and the new blood test. The new blood test may be able to detect rejection as early as 28 days after heart transplantation and at least three months before rejection is detectable using heart tissue biopsy.
At Wellness Axis we want to encourage habits of wellness, Increase awareness of factors and resources contributing to well-being, Inspire and empower individuals to take responsibility for their own health, and to support a sense of community. Wellness can be thought of as the quality or state of being in good health.